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	 Selective	 and	 sensitive	 ultra‐performance	 liquid	 chromatography‐tandem	 mass
spectrometric	technique	(UPLC‐MS/MS)	was	investigated	for	simultaneous	determination	of
acemetacin	(ACM)	in	presence	of	its	metabolite	(indomethacin)	and	degradation	products	in
3	min	run	time.	The	column	employed	was	a	Hypersil	gold	50	mm	×	2.1	mm	(1.9	μm)	with	an
isocratic	 mobile	 phase	 consisted	 of	 0.1%	 formic	 acid	 aqueous	 solution	 and	 acetonitrile
(10:90,	v:v)	 	with	 flow	 rate	250	µL/min.	Detection	of	 the	 cited	 drug	was	 carried	out	using
multiple	 reaction	 monitoring	 (MRM)	 mode	 on	 a	 triple	 quadrupole	 mass	 spectrometer
coupled	with	electrospray	ionization	(ESI)	m/z	416.44	→	139.24	for	ACM	and	m/z	256.31	→
167.00	 for	 diphenhydramine	 internal	 standard.	 Various	 parameters	 were	 studied;	 mobile
phase	composition,	flow	rate,	rate	of	fragmentation,	rate	of	collision	and	mode	of	ionization.
Good	linear	relationship	was	obtained	in	concentration	range	8.0‐500.0	ng/mL	(r	=	0.9994).
The	method	was	validated	 (linearity,	 range,	precision,	 accuracy,	 limit	of	quantification	and
limit	 of	 detection)	 according	 to	 ICH	 guidelines	 and	 there	 is	 no	 significance	 difference
between	 the	 proposed	 method	 and	 the	 reference	 HPLC	 method	 regarding	 accuracy	 and
precision.	The	simplicity	and	sensitivity	of	this	method	allows	its	use	as	stability	indicating
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1.	Introduction	
	
Acemetacin	 ACM,	 (2‐[2‐[1‐(4‐chlorobenzoyl)‐5‐methoxy‐
2‐methylindol‐3‐yl]	 acetyl]oxyacetic	 acid)	 is	 a	 non‐steroidal	
anti‐inflammatory	 drug,	 used	 for	 the	 treatment	 of	 osteo‐
arthritis	 and	 rheumatoid	 arthritis	 (Figure	 1).	 It	 is	 a	 glycolic	
acid	ester	of	 indometacin,	acts	as	a	prodrug;	 in	 the	body,	 it	 is	
metabolized	 to	 indomethacin,	which	 then	acts	as	an	 inhibitor	
of	cyclooxygenase,	producing	the	anti‐inflammatory	effects.	An	
advantage	 of	 acemetacin	 is	 that	 it	 reduces	 gastric	 damage	
when	compared	to	indomethacin	[1].		
Literature	 survey	 reveals	 that	 there	 are	 several	methods	
have	been	investigated	for	the	determination	of	ACM,	such	as	
spectrophotometric	 [2‐4],	chromatographic	[2‐6]	and	voltam‐
metric	 methods	 [7,8].	 The	 British	 Pharmacopoeia	 [9]	
described	 indomethacin	 and	 p‐chlorobenzoic	 acid	 (PCBA)	 as	
impurities	 for	 ACM.	 p‐Chlorobenzoic	 acid	 and	 5‐methoxy‐	
2‐methyl‐3‐indole	acetic	acid	are	reported	as	the	degradation	
products	 under	 specific	 alkaline	 and	 acidic	 stress	 conditions	
[5].	These	degradation	products	obtained	were	 confirmed	by	
their	m/z	using	UPLC‐MS/MS.		
	
 
	
Figure	1.	Structure	of	acemetacin.	
	
To	 our	 knowledge,	 there	 is	 no	 validated	 UPLC‐MS/MS	
method	 was	 developed	 for	 the	 determination	 of	 ACM	 in	
presence	 of	 its	 metabolite	 (indomethacin)	 and	 degradation	
products.	 Therefore,	 the	 aim	 of	 this	 paper	 was	 to	 develop	 a	
validated,	 sensitive,	 selective	and	rapid	UPLC‐MS/MS	method	
for	 the	 simultaneous	 analysis	 of	 the	 cited	 drug	 in	 pure	 form	
and	 pharmaceutical	 dosage	 form,	 also	 in	 presence	 of	 its	
degradation	products	 and/or	metabolite.	Different	 chromato‐
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graphic	 parameters	 and	mass	 spectrometric	 conditions	were	
investigated	 to	 select	 the	 optimum	 conditions	 for	 the	
separation.	This	 technique	couples	high	resolution	chromato‐
graphic	 separation	 with	 sensitive	 and	 specific	 mass	
spectrometric	 detection,	 which	 is	 clearly	 advantageous,	
particularly	 because	 many	 compounds	 with	 similar	 or	
identical	 retention	 characteristics	 have	 quite	 different	 mass	
spectra	and	can	therefore	be	differentiated	[10].	
	
2.	Experimental	
	
2.1.	Materials	
	
Acemetacin	 (99.73%)	 and	 indomethacin	 (100.36%)	were	
kindly	supplied	by	the	National	Organization	for	Drug	Control	
and	Research	(NODCAR),	Cairo,	Egypt.	Pharmaceutical	dosage	
forms;	Ost‐Map	capsules	(60	mg	ACM/capsule)	manufactured	
by	Multi‐Apex	Pharmaceutical	Industries,	Badr	City,	Egypt.	
	
2.2.	Chemicals	and	reagents	
	
All	 chemicals	 used	were	 of	 analytical	 grade	 and	 solvents	
were	 of	 HPLC	 grade.	 Diphenhydramine	 (IS),	 methanol,	
acetonitrile	 and	 formic	 acid	 were	 purchased	 from	 Sigma‐
Aldrich,	Germany.	Sodium	hydroxide,	hydrochloric	acid	(32%,	
w:v)	 were	 purchased	 from	 El‐Nasr	 Company,	 Egypt.	 Pure	
deionized	water	was	obtained	by	Elga	Labwater,	Prima	7,	UK.	
	
2.3.	Instrumentations	
	
The	 analysis	 was	 achieved	 using	 a	 TSQ	 Quantum	 Access	
MAX	 triple	 stage	 quadrupole	 mass	 spectrometer,	 Thermo	
Scientific,	 New	 York,	 USA,	 equipped	 with	 an	 electrospray	
ionization	 (ESI)	source.	The	control	of	 the	LC‐MS/MS	system,	
acquisition	and	analysis	of	 the	data	were	performed	utilizing	
Xcalibur	software	version	2.2.	Chromatography	was	carried	on	
Accela	 U‐HPLC	 system	 which	 was	 composed	 of	 Accela	 1250	
quaternary	 pump	 and	 Accela	 open	 autosampler,	 New	 York,	
USA	(operated	at	25	°C).	
	
2.4.	Chromatographic	and	mass	spectrometric	conditions	
	
Chromatographic	 separation	 was	 performed	 on	
HypersilGold	 column	 (C18‐bonded	 ultrapure	 silica	 based	
column)	50	mm	×	2.1	mm	(1.9	µm)	preceded	by	a	C18	security	
guard	 cartridge	Gemini	 5	 μm	C18	 (Phenomenex)	 4	×	 3	mm).	
Isocratic	 elution	was	 achieved	 using	mobile	 phase	 consisting	
of	0.1%	formic	acid	aqueous	solution	and	acetonitrile	(10:90,	
v:v)	 and	 flow	 rate	 of	 250	 µL/min,	 where	 elution	 was	
performed	at	room	temperature.	The	injection	volume	was	10	
µL	and	the	total	run	time	for	each	sample	was	3	min.	The	mass	
spectrometric	 detection	 method	 was	 carried	 out	 in	 the	
positive‐ion	 mode	 in	 case	 of	 ACM,	 indomethacin	 and	
5‐methoxy‐2‐methyl‐3‐indole	acetic	acid	and	negative	one	for	
PCBA	 utilizing	 electrospray	 ionization	 (ESI)	 and	 multiple	
reactions	monitoring	 (MRM).	 Samples	 are	 individually	 tuned	
for	 each	 target	 analyte	 by	 direct	 injection	 of	 the	 individual	
solution	 followed	 by	 data	 acquisition	 and	 processing.	 The	
optimized	parameters	are:	auxiliary	gas	of	2	psi,	sheath	gas	of	
20	 psi,	 capillary	 temperature	 of	 270	 °C,	 turbo	 ion	 spray	
temperature	 of	 400	 °C,	 capillary	 offset	 35	 and	 ion	 spray	
voltage	 of	 3600	 V.	 The	 quadrupole	 mass	 spectrometer	 was	
operated	 at	 the	 MRM	 mode,	 monitoring	 the	 transition	 of	
molecular	 ions	 to	 the	 product	 ions	 for	 ACM	m/z	 416.44	 →	
139.24	 and	 IS	m/z	 256.31	 →	 167.00.	 The	 collision	 energies	
were	22	and	25	eV	for	ACM	and	IS,	respectively.	
	
2.5.	Standard	Solutions	
	
Standard	 stock	 solutions	 of	 100	 µg/mL	 for	 ACM	 and	
indomethacin	 were	 prepared	 separately	 in	 methanol	 and	
stored	 in	refrigerator.	Sample	degradation:	ACM	pure	sample	
was	subjected	 to	 forced	degradation	under	different	 stressed	
conditions	 as,	 alkaline	 (0.1	 N	 NaOH	 for	 30	 min	 at	 room	
temperature)	 or	 acidic	 (reflux	 with	 0.1	 N	 HCl	 for	 3	 hrs	 in	
boiling	water	bath)	then	neutralized	as	reported	[5].		
	
2.6.	Procedures		
	
2.6.1.	Calibration	curve	
	
Working	 standard	 solutions	 of	 ACM	 (8.0‐500.0	 ng/mL)	
were	prepared	by	 serial	 dilutions	 of	 aliquots	 of	 the	 standard	
stock	 solution	 with	 methanol.	 5	 ng/mL	 of	 IS	 was	 added	 for	
each	solution	then	10	μL	of	each	solution	was	injected	into	the	
LC‐MS/MS	 system.	 The	 relative	 peak	 areas	 of	 the	 drug	were	
plotted	 versus	 the	 concentrations	 of	 drug	 in	 ng/mL	 and	 the	
corresponding	regression	equation	was	derived.	
	
2.6.2.	Analysis	of	ACM	pure	sample		
	
An	 aliquot	 of	 10	 µL	 of	 different	 ACM	 working	 standard	
solutions	covering	the	concentration	range	(8.0‐500.0	ng/mL)	
was	injected	into	UPLC‐MS/MS	and	measured	by	the	proposed	
method.	The	percentage	recoveries	were	calculated	by	means	
of	the	regression	equation	or	from	the	calibration	graph.		
	
2.6.3.	Analysis	of	laboratory	prepared	mixtures	containing	
different	concentrations	of	ACM,	indomethacin	and	its	
degradation	products	
	
Aliquots	 of	 ACM	working	 standard	 solutions	were	mixed	
with	indomethacin	and	degradation	products	and	determined	
by	 the	 proposed	 method.	 The	 concentrations	 of	 ACM	 were	
calculated	from	the	regression	equation.	
	
2.6.4.	Analysis	of	pharmaceutical	dosage	form	
	
The	contents	of	ten	capsules	of	Ost‐Map	were	weighed	and	
mixed	well.	 An	 accurately	 amount	 claimed	 to	 be	 10	mg	ACM	
was	mixed	with	100	mL	methanol	 then	sonicated	for	30	min.	
The	 solution	 was	 filtrated	 and	 completed	 as	 under	 Section	
2.6.1.	 The	 concentrations	 of	 ACM	 were	 calculated	 from	 the	
corresponding	regression	equation.	
	
3.	Results	and	discussion	
	
The	 proposed	 UPLC‐MS/MS	 method	 permits	 the	
quantification	of	ACM	 in	pure	material	 and	 in	presence	of	 its	
metabolite	(indomethacin)	and	two	degradation	products.	The	
method	suggests	high	sensitivity	and	selectivity	for	ACM.	
	
3.1.	Selection	and	optimization	of	chromatographic	
condition	and	mass	spectrometric	detection	
	
To	 achieve	 the	 best	 chromatographic	 conditions:	 mobile	
phase	 composition	 and	 flow	 rate	were	 carefully	 studied	 and	
optimized	 to	provide	sufficient	selectivity	and	sensitivity	 in	a	
short	separation	time.	So,	isocratic	elution	using	mobile	phase	
consisting	 of	 0.1%	 formic	 acid	 aqueous	 solution	 and	
acetonitrile	(10:90,	v:v),	flow	rate	of	250	µL/min	and	injection	
volume	10	 µL,	 performed	 at	 room	 temperature	 allowed	high	
resolution	and	separation	of	each	analyt	(ACM,	indomethacin,	
degradates	and	IS).	
For	mass	spectrometry,	different	parameters	were	studied	
as,	sheath	gas	pressure,	spray	voltage,	collision	energy,	rate	of	
fragmentation,	mode	of	ionization,	etc.	The	selected	conditions	
(under	 Section	 2.4)	 permitted	 good	 separation	 in	 short	 time	
(less	 than	1	min).	The	optimized	MRM	transitions	 (precursor	
ion	m/z	 →	 product	 ion	m/z)	 are	 ACM	m/z	 416.44	→	 139.24	
and	 IS	m/z	 256.31	→	 167.00,	where,	 full	 scan	 for	 PCBA	m/z	
156.32	 →	 156.32,	 5‐methoxy‐2‐methyl‐3‐indole	 acetic	 acid	
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m/z	220.30	→	220.30	and	indomethacin	m/z	358.35	→	358.35	
(Figure	 2).	 ACM	 was	 fragmented	 into	 different	 product	 ions	
m/z	 139.24,	 111.28	 and	 174.30,	 but	 we	 selected	 139.24	
because	it	gave	high	intensity	(Figure	3	and	4).		
	
	
Figure	 2.	 Chromatographic	 separation	 of	 PCBA,	 5‐methoxy‐2‐ methyl
‐3‐indole	acetic	acid,	indomethacin	and	ACM,	respectively,	by	the	proposed	
UPLC‐MS/MS.	
	
	
 
	
Figure	3.	Breakdown	curve	of	ACM	m/z	416.44	→	139.24,	111.3	and	174.3.
	
	
 
	
Figure	4.	Product	ion	spectra	of	ACM	[M+H]+,	m/z	139.2,	111.3	and	174.3.
	
	
3.2.	Degradation	
	
ACM	under	different	stressed	acidic	(reflux	with	0.1	N	HCl	
for	3	hrs	in	boiling	water	bath)	and	basic	(0.1	N		NaOH	for	30	
min	 at	 room	 temperature)	 conditions	 undergo	 complete	
degradation,	 where	 it	 is	 stable	 under	 oxidative	 and	 thermal	
stress	 conditions	 as	 reported	 [5].	 ACM	 was	 degradated	 into	
PCBA	 and	 5‐methoxy‐2‐methyl‐3‐indole	 acetic	 acid	 as	
reported	[5],	which	confirmed	by	their	molecular	weights	m/z	
156.32,	220.30	using	the	proposed	method	(Full	scan).	So,	by	
applying	 the	 proposed	 UPLC‐MS/MS	 technique,	 it	 was	
probable	 to	 detect	 ACM	 in	 the	 presence	 of	 its	 metabolite	
and/or	degradation	products	in	short	time	(˂	1	min)	as	shown	
in	Figure	2.	
	
3.3.	Method	validation	
	
The	 method	 was	 validated	 according	 to	 ICH	 guidelines	
regarding	 linearity,	 range,	 limit	 of	 detection,	 limit	 of	
quantification,	accuracy	and	precision	[11].	
	
3.3.1.	Linearity	and	range	
	
Under	the	above‐described	experimental	conditions,	linear	
relationships	were	established	by	plotting	relative	peak	areas	
against	 ACM	 concentrations.	 The	 concentration	 range	 was	
found	linear	in	8.0‐500.0	ng/mL.	Linear	regression	analysis	of	
the	data	gave	the	following	equation	(Table	1):	
	
A	=	‐1.044	+	0.6353	×	C						(r	=	0.9994)		 	 (1)	
	
where	A	is	the	relative	peak	areas	and	C	is	the	concentration	of	
drug	 in	 ng/mL	 and	 r	 is	 the	 regression	 coefficient.	 The	 high	
values	 of	 the	 correlation	 coefficients	 (>	 0.999)	 indicate	 good	
linearity	of	the	calibration	graphs	(Figure	5)	
	
	
	
Figure	 5.	 Calibration	 curve	 of	 ACM	 (8.0‐500.0	 ng/mL)	 by	 the	 proposed	
UPLC‐MS/MS method.
	
	
3.3.2.	Limit	of	quantitation	(LOQ)	and	limit	of	detection	
(LOD)	
	
The	 minimum	 level	 at	 which	 the	 ACM	 can	 be	 reliably	
detected	(LOD)	and	quantified	(LOQ)	were	determined	and	the	
data	are	presented	in	Table	1.	
	
3.3.3.	Accuracy	and	precision	
	
The	 accuracy	 of	 the	 proposed	 method	 was	 evaluated	 by	
assay	of	ACM	standard	solutions	by	the	proposed	method	and	
the	results	obtained	were	compared	with	those	obtained	using	
the	reported	one	[5].	Statistical	analysis	of	the	results	obtained	
by	 the	proposed	and	reported	methods	using	student´s	 t‐test	
and	variance	ratio	F‐test,	showed	no	significant		 difference	
between	the	two	methods	(Table	2).	
Evaluation	 of	 the	 intra‐day	 precision	 was	 made	 by	
replicate	assay	of	the	standard	solutions	of	the	studied	drug	on	
the	 same	 day,	 while	 the	 inter‐day	 precision	 was	 evaluated	
through	replicate	the	assay	on	three	successive	days	(Table	2).	
The	 values	 of	 standard	 deviation	 (SD)	 were	 small	 what	
indicates	that	the	repeatability	of	the	proposed	method	is	good	
and	 the	 suitability	 of	 the	 LC‐MS/MS	method,	 for	 the	 routine	
detection	 of	 ACM	 in	 presence	 of	 its	 metabolite	 and	
degradations	products.	
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Table	1.	Validation	parameters	for	the	determination	of	pure	ACM	by	the	proposed	UPLC‐MS/MS	method.	 	
Parameter	 ACM	
Range	(ng/mL)	 8.0‐500.0
Slope	 0.6353
Intercept	 ‐1.044	
Correlation	coefficient	(r)	 0.9994	
LOD	(ng/mL)	 2.52	
LOQ	(ng/mL)	 7.64	
	
	
Table	2.	Accuracy	and	precision	of	the	proposed	UPLC‐MS/MS	method	for	the	determination	of	pure	ACM.	
Parameter	 Proposed	UPLC‐MS/MS	 Reported	HPLC	[5]	
Mean±SD	 101.10±0.719 100.62±0.818	
Variance	 0.517 0.669
N	 6 6
Student´s	t‐test	(2.228)	*	 0.790
F‐test	(5.050)	*	 1.294
Intra‐day	precision	 100.64±1.430	 	
Inter‐day	precision	 101.29±1.931	 	
*	The	values	in	the	parentheses	are	the	corresponding	tabulated	values	at	p	=	0.05.	
	
	
Table	3.	Application	of	the	proposed	method	for	the	determination	of	ACM	in	Ost‐Map	capsules.	
Parameter	 Proposed	UPLC‐MS/MS Reported	HPLC	[5]	
Mean±SD	 99.669±3.068 98.031±1.978	
Variance	 9.413 3.912
N	 6 6
Student´s	t‐test	(2.228)	*	 0.769
F‐test	(5.050)	*	 2.406	 	
*	The	values	in	the	parentheses	are	the	corresponding	tabulated	values	at	p	=	0.05.	
	
	
3.3.4.	Robustness	of	the	method	
	
The	 robustness	 of	 analytical	 method	 measures	 the	
capacity	 of	 it	 to	 restrain	 small	 but	 deliberate	 changes	 in	
method	 parameters.	 Evaluation	 of	 the	 robustness	 of	 the	
proposed	 method	 was	 done	 for	 the	 chromatographic	
parameters	 as	well	 as,	 the	mass	parameters	 ,e.g.	 flow	 rate	 of	
mobile	phase	(±10	μL/min),	vaporizer	temperature	or	transfer	
capillary	 temperature	 (±5	 °C),	 collision	 energy	 (±2	 V)	 and	
sheath	gas	pressure	(±5	psi)	did	not	show	significant	changes	
in	the	values	of	peak	areas	of	ACM.	
	
3.4.	Application	of	the	proposed	method	
	
The	 proposed	 UPLC‐MS/MS	 method	 was	 successfully	
applied	for	the	determination	of	ACM	in	 its	dosage	form	with	
satisfactory	recovery.	The	obtained	results	are	 listed	in	Table	
3.	
	
4.	Conclusion		
	
Specific	 and	 sensitive	 ultra‐performance	 liquid	 chroma‐
tography	 coupled	 to	 tandem	 mass	 spectrometric	 technique	
(UPLC‐MS/MS)	 was	 developed	 for	 simultaneous	 determi‐
nation	 of	 acemetacin	 (ACM)	 in	 presence	 of	 its	 metabolite	
(indomethacin)	 and	 degradation	 products.	 Different	 chroma‐
tographic	parameters	and	mass	spectrometric	conditions	were	
investigated	 to	 select	 the	 optimum	 conditions	 for	 the	
separation.	 The	 method	 was	 validated	 according	 to	 ICH	
guidelines	 and	 successfully	 applied	 for	 the	 determination	 of	
cited	drug	in	dosage	form.	
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